Agenus (AGEN)
(Delayed Data from NSDQ)
$16.60 USD
+0.04 (0.24%)
Updated Jun 7, 2024 04:00 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Agenus Inc. [AGEN]
Reports for Purchase
Showing records 81 - 100 ( 258 total )
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
AGEN1884 Results at ASCO; New Cell Therapy Subsidiary Planned; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
The Power of One: The Future of Personalized Cancer Therapy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Our Perspective on Emerging Trends in Checkpoint Immunotherapy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Status Quo for Now; Potential Pipeline Related Catalysts in 2H17; Reiterate Hold
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Incyte Agreement Solidifies Cash Position; Questions Regarding Development Programs Remain; Reiterate Hold
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Our Perspective on Trends and Developments in GBM Immunotherapy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Lack of Major Catalysts Renders Shares Range-Bound; Downgrade to Neutral With a $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S